Waystar - AI Stock Analysis

Analysis generated May 8, 2026

Waystar is a healthcare technology company focused on providing improved revenue cycle management solutions. The company offers a range of cloud-based software solutions that help organizations within the healthcare industry optimize their financial operations. Waystar has shown significant growth and adaptability in its market, demonstrating strong capabilities in enhancing the operational efficiency of healthcare providers.

Fundamental Analysis

Waystar reported a revenue of $304 million for the last quarter, marking an increase of 12.99% from the previous quarter. This is a substantial sign of growth, showing an upward trend. Year-over-year, Waystar experienced a 24.35% increase in revenue, reflecting robust business expansion over the past year.

However, the net income for the last quarter was $20 million, a significant decrease of 34.78% compared to the previous quarter. Although there is a year-over-year increase of 4.76% in net income, the quarter-over-quarter decline warrants careful scrutiny and could be a potential red flag.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) stood at $129 million for the last quarter. This represents a sizable increase of 38.91% compared to the previous quarter and a 41.13% year-over-year growth. This strong EBITDA growth indicates that the company's core operations remain efficient and profitable.

Waystar's current Price-to-Earnings (P/E) ratio is 31.36, considered relatively high. This may imply that the stock is overvalued and can support a bearish outlook from cautious investors.

Technical Analysis

The stock price of Waystar is currently $20.89, reflecting a decrease of 7.77% from a month ago. This short-term decline could be indicative of investor concerns or market volatility. Over a longer-term perspective, the stock price has decreased by 47.79% compared to a year ago, posing questions about the company's ability to sustain investor confidence over time.

The trend remains bearish, as evidenced by the Simple Moving Average (SMA10) data. The current SMA10 is 21.28, compared to the previous SMA10 of 21.71, suggesting a potential downward trajectory in price movement. The Relative Strength Index (RSI) is 34.2, indicating a neutral condition but bordering the oversold territory, which may eventually lead to a trading opportunity for some investors.

Alternative Data Analysis

Job postings and employee sentiment provide additional insights into Waystar’s health. The company has consistently maintained around 102 open positions over recent months, suggesting stability. Moreover, 83% of employees have a positive outlook on the business, further reinforcing confidence in the company's internal environment.

Waystar's customer engagement is on the rise, with an estimated 250,000 visitors to their webpage, an increase of 41% in the last few months. This bullish trend could signal increased customer interest and potential revenue growth.

The company’s social media presence remains static, with about 2,000 followers on Twitter and no significant changes to report. However, it's worth noting that AltIndex AI, which combines fundamental, technical, and alternative data to predict stock prices, scored Waystar at 77, suggesting a buy signal.

Conclusion and Recommendation

In conclusion, Waystar showcases several positive indicators in terms of revenue growth, EBITDA improvement, and employee sentiment. However, the significant drop in net income and a high P/E ratio could signal caution. The technical analysis reflects a bearish trend and a potentially overvalued stock price. Nevertheless, the alternative data presents a stable employee outlook and increasing customer interest, contributing positively to the overall picture.

Given the blend of these insights, prospective investors should consider the potential risks associated with the company's current stock valuation and bearish trend, balanced with the firm’s solid fundamentals and positive alternative data signals. An informed decision should be based on one’s risk tolerance and investment horizon.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.